- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Nerac Medical Device Analyst Perry De Fazio will discuss how medical device companies can assess whether a new technology will disrupt the market during an MDM Webinar at 2 p.m. EDT Oct. 8, 2008. He also will reveal how companies can identify emerging technologies that present potential business opportunities.
When to invest in a technology as it emerges is a critical question that can affect a company's future. De Fazio will examine three important trends and emerging technologies and how they will impact the medical device industry in the future:
-- Breakthroughs and potential applications of nanotechnology
-- Technologies to monitor as FDA and supply chain stakeholders move
toward implementing Unique Device Indentifiers, or UDIs
-- Advances in minimally invasive surgeries and technological factors
influencing natural orifice surgery
To register for the free one-hour webinar, please visit
As a Nerac analyst, De Fazio provides companies in the medical device industry with insight into the potential of untapped markets and disruptive technologies. From multi-billion-dollar multinationals to small start-ups, he advises innovators on the development of new technologies and helps vet technologies for license and acquisition. Mr. De Fazio has nine years of industry experience as a project engineer at Boston Scientific Corporation, an R&D engineer at Tissuelink Medical, and a senior engineer at Ortheon Medical.
MDMwebinars.com provides free, live and on-demand webinars for the medical manufacturing industry. The webinars are produced by Canon Communications, the medical manufacturing industry's leading publisher, conference and trade event producer and digital media company.
About Nerac Inc.
Nerac Inc., based in Tolland, CT, is a research and advisory firm for companies developing innovative products and technologies. Nerac Analysts deliver custom assessments of product and technology development opportunities, competitor intelligence, intellectual property strategies, and compliance requirements through a proven blended approach to custom analysis: review of technical knowledge, investigation of intellectual property, and appraisal of business impacts. Nerac deploys analysts in diverse disciplines to help clients discover new applications, serving as a catalyst for new thinking and creative approaches to business problems or identifying strategic growth opportunities.
For more information, please click here
Copyright © PR Newswire Association LLC.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Richards-Kortum elected to American Academy of Arts and Sciences: April 22nd, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015